Musculoskeletal Disease in MDA5‐Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's Arthropathy
Objective To define the molecular basis of a multisystem phenotype with progressive musculoskeletal disease of the hands and feet, including camptodactyly, subluxation, and tendon rupture, reminiscent of Jaccoud's arthropathy. Methods We identified 2 families segregating an autosomal‐dominant p...
Saved in:
Published in | Arthritis & rheumatology (Hoboken, N.J.) Vol. 69; no. 10; pp. 2081 - 2091 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
To define the molecular basis of a multisystem phenotype with progressive musculoskeletal disease of the hands and feet, including camptodactyly, subluxation, and tendon rupture, reminiscent of Jaccoud's arthropathy.
Methods
We identified 2 families segregating an autosomal‐dominant phenotype encompassing musculoskeletal disease and variable additional features, including psoriasis, dental abnormalities, cardiac valve involvement, glaucoma, and basal ganglia calcification. We measured the expression of interferon (IFN)–stimulated genes in the peripheral blood and skin, and undertook targeted Sanger sequencing of the IFIH1 gene encoding the cytosolic double‐stranded RNA (dsRNA) sensor melanoma differentiation–associated protein 5 (MDA‐5). We also assessed the functional consequences of IFIH1 gene variants using an in vitro IFNβ reporter assay in HEK 293T cells.
Results
We recorded an up‐regulation of type I IFN–induced gene transcripts in all 5 patients tested and identified a heterozygous gain‐of‐function mutation in IFIH1 in each family, resulting in different substitutions of the threonine residue at position 331 of MDA‐5. Both of these variants were associated with increased IFNβ expression in the absence of exogenous dsRNA ligand, consistent with constitutive activation of MDA‐5.
Conclusion
These cases highlight the significant musculoskeletal involvement that can be associated with mutations in MDA‐5, and emphasize the value of testing for up‐regulation of IFN signaling as a marker of the underlying molecular lesion. Our data indicate that both Singleton‐Merten syndrome and neuroinflammation described in the context of MDA‐5 gain‐of‐function constitute part of the same type I interferonopathy disease spectrum, and provide possible novel insight into the pathology of Jaccoud's arthropathy. |
---|---|
Bibliography: | Dr. Ehmke's work was supported by the Clinician Scientist Program funded by the Charité–Universitätsmedizin Berlin and the Berlin Institute of Health. Dr. Crow's work was supported by the European Research Council (grant GA309449) and a state subsidy managed by the National Research Agency, France (Investments for the Future grant ANR‐10‐IAHU‐01). Drs. de Carvalho, Ngoumou, and Ehmke and Mr. Park contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 All authors were involved in drafting the article or revising it critically for important intellectual content, and all authors approved the final version to be published. Dr. Crow had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. AUTHOR CONTRIBUTIONS |
ISSN: | 2326-5191 2326-5205 |
DOI: | 10.1002/art.40179 |